Skip to content
Open access · CC-BY via OpenAlex

Cycloastragenol and Astragaloside IV activate telomerase and protect nucleus pulposus cells against high glucose‑induced senescence and apoptosis

Haofeng Hong, Jian Xiao, Quanquan Guo, Jinhui Du, Zhichen Jiang, Sisi Lu, Hongyuan Zhang, Xiaolei Zhang, Xiangyang Wang

Experimental and Therapeutic Medicine · 2021 · ▲ 47 citations

Abstract

, Cycloastragenol (CAG) and Astragaloside IV (AG-IV), are reportedly effective telomerase activators against telomere(definition) shortening; however, their effect in Db-IVDD have not been explored. The present study simultaneously investigated the regulation of these derivatives on senescence(definition), apoptosis, telomeres and telomerase a model of high-glucose (HG)-induced stress using rat primary NPCs. The NPCs were stimulated with HG (50 mM) to evoke HG-induced stress, and the effects of CAG and AG-IV were observed on: i) The expression level of senescence marker p16; ii) β-Gal staining; iii) the expression levels of apoptosis markers cleaved-caspase 3 (c-C3), BAX and Bcl-2; iv) telomerase activation with telomerase reverse transcriptase (TERT) mRNA and protein expression, while telomere length was measured with reverse transcription-quantitative PCR. Cell proliferation was determined using the Cell Counting Kit-8 assay. Results demonstrated an upregulation in the expression levels of p16, c-C3 and BAX, and increased β-Gal staining; while the expression level of Bcl-2 was downregulated in a concentration-dependent manner. Pre-treatment of the NPCs with CAG and AG-IV downregulated the protein expression levels of p16, c-C3 and BAX, and decreased the percentage of β-Gal and FITC staining; while upregulating the Bcl-2 expression. These effects protected the cells from HG stress-induced senescence and apoptosis. HG also downregulated the expression profile of TERT and shortened the telomere length in a glucose concentration-dependent manner. While pretreatment with CAG and AG-IV upregulated TERT expression and ameliorated the telomere attrition. CAG and AG-IV also increased cell proliferation and improved cell morphology in HG conditions. Overall, these findings indicated that CAG and AG-IV suppressed HG stress-induced senescence and apoptosis, in addition to enhancing telomerase activation and lengthening of the Telomere. Therefore, CAG and AG-IV prolonged the replicative capability and longevity of the NPCs and they have the potential to be therapeutic agents in Db-IVDD.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
OpenAlex
DOI
10.3892/etm.2021.10761
Canonical
link ↗
Fetched
2026-11-01 MST

Cite this

APA
Hong, H., Xiao, J., Guo, Q., Du, J., Jiang, Z., Lu, S., Zhang, H., Zhang, X., &amp; Wang, X. (2021). Cycloastragenol and Astragaloside IV activate telomerase and protect nucleus pulposus cells against high glucose‑induced senescence and apoptosis. <em>Experimental and Therapeutic Medicine</em>. https://doi.org/10.3892/etm.2021.10761
Vancouver
Hong H, Xiao J, Guo Q, Du J, Jiang Z, Lu S, et al. Cycloastragenol and Astragaloside IV activate telomerase and protect nucleus pulposus cells against high glucose‑induced senescence and apoptosis. Experimental and Therapeutic Medicine. 2021. doi:10.3892/etm.2021.10761.
BibTeX
@article{haofeng2021Cycloa, title = {Cycloastragenol and Astragaloside IV activate telomerase and protect nucleus pulposus cells against high glucose‑induced senescence and apoptosis}, author = {Haofeng Hong and Jian Xiao and Quanquan Guo and Jinhui Du and Zhichen Jiang and Sisi Lu and Hongyuan Zhang and Xiaolei Zhang and Xiangyang Wang}, journal = {Experimental and Therapeutic Medicine}, year = {2021}, doi = {10.3892/etm.2021.10761}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings